Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Causes of Alopecia Can Vary Among Patients with Systemic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting

Susan Bernstein  |  Issue: March 2014  |  March 1, 2014

2013 ACR/ARHP Annual Meeting: Alopecia

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

SAN DIEGO—Rheumatologists may encounter patients with systemic disease who present with various forms of alopecia that seem sudden or unusual. Hair loss can be caused by autoimmune inflammation in some cases, but there are many other potential causes that a rheumatologist must explore to treat the condition effectively.

Rheumatologists often may see a patient presenting with a complaint of hair loss, especially those with autoimmune diseases like systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA), said Maria K. Hordinsky, MD, chair of the department of dermatology at the University of Minnesota in Minneapolis during her presentation at the 2013 ACR/ARHP Annual Meeting. “Even though you have done a great job of treating their connective tissue disease,” alopecia can still occur. [Editor’s Note: This session was recorded and is available via ACR SessionSelect at www.rheumatology.org.]

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Hair Sheds Daily

Looking at a cross-section image of a normal scalp, about 90% of the hair follicles look the same, Dr. Hordinsky said. However, hair shedding and even pattern baldness are common among almost all adults. “Every day, we shed hair fibers. There is always recycling going on,” she said. Hair production goes through three cycles: anagen (actively growing), catagen (involution of growth), and telogen (resting). Telogen effluvium is the general term for pattern hair loss. “When patients come to you complaining that their hair is coming out at the roots, what they are losing are the telogen fibers,” she said. Stem cells are located in the bulge region near the base of the hair follicle, she noted.

Alopecia has a psychological impact for many patients, and they may try to hide their hair loss with caps, scarves, or hairpieces. It’s important for rheumatologists to not assume telogen effluvium is simply female pattern baldness but to examine the scalp closely and consider many possible causes, Dr. Hordinsky said. Ascertain if the patient’s family has a history of baldness, and also check for nail abnormalities, menstrual irregularities, or pregnancy, as well as asking about excess body hair, which the patient may have waxed or shaved, she suggested.

Looking closely at the scalp for symptoms like burning, pruritus, pain, redness, scaling, folliculitis, or scarring may provide more clues to the cause of the hair loss. Look at the pattern of hair loss as well as whether or not there is new hair growth visible. A “pull test” is standard. If six or more hairs from any site on the scalp fall out with gentle pulling, this is a sign of diffuse alopecia areata (AA), an autoimmune disease, she said. Standardized scales help categorize the level of alopecia; female pattern baldness is measured on the Ludwig scale, and male pattern baldness is measured on the Hamilton-Norwood scale.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RACR/ARHP Annual MeetingalopeciaAmerican College of Rheumatology (ACR)anti-inflammatoryCausedrugHYDROXYCHLOROQUINELupusMethotrexatepatient careRheumatic DiseaseRheumatoid arthritisSystemic lupus erythematosus

Related Articles

    Tips for Treating Lupus-Related Renal Disease, Pain, Alopecia

    January 19, 2018

    SAN DIEGO—Rheumatologists who treat lupus patients gleaned tips on diagnosis and management of renal disease, painful neuropathies and alopecia at a “Curbside Consults” session held Nov. 6 at the ACR/ARHP Annual Meeting in San Diego. Membranous Lupus Nephritis Patients with refractory membranous lupus nephritis (MLN), or Class V lupus nephritis, face “significant morbidity, most of…

    Hair dye being applied to a man’s beard.

    Case Report: A 50-Year-Old Man Suffers Dye-Induced Arthritis

    December 18, 2019

    Hair dye products are commonly used by both men and women to enhance youth and beauty and to follow fashion trends. As reported in the medical literature, hair dyes and their ingredients are associated with allergic contact dermatitis. A possible association with joint inflammation has also been recognized. There is literature to support that para-phenylenediamine…

    New Research Points to Possible Future Treatment Option for Alopecia Areata

    October 24, 2014

    Topical application of protein tyrosine kinase inhibitors shown to reverse mouse model of the disease

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences